M. Kohnle, F. Pietruck, A. Kribben, T. Philipp, U. Heemann et al., Ezetimibe for the Treatment of Uncontrolled Hypercholesterolemia in Patients with High-Dose Statin Therapy After Renal Transplantation, American Journal of Transplantation, vol.44, issue.1, pp.205-208, 2006.
DOI : 10.1073/pnas.0500269102

A. Jardine, H. Holdaas, B. Fellstrom, E. Cole, G. Nyberg et al., Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post-Hoc Subgroup Analyses of the ALERT Study, American Journal of Transplantation, vol.10, issue.6, pp.988-995, 2004.
DOI : 10.1053/ajkd.2002.34927

M. Duarte, J. Rocha, R. Moresco, T. Duarte, D. Cruz et al., Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia, Clinical Biochemistry, vol.42, issue.7-8, pp.666-671, 2009.
DOI : 10.1016/j.clinbiochem.2009.01.010

K. Raman, R. Gandley, J. Rohland, and M. Zenati, Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide, Journal of Vascular Surgery, vol.53, issue.3, pp.754-763, 2011.
DOI : 10.1016/j.jvs.2010.09.038

F. Favreau, R. Thuillier, J. Cau, S. Milin, E. Manguy et al., Anti-thrombin Therapy During Warm Ischemia and Cold Preservation Prevents Chronic Kidney Graft Fibrosis in a DCD Model, American Journal of Transplantation, vol.129, issue.Suppl
DOI : 10.1111/j.1600-6143.2009.02924.x

B. Kasiske, F. Cosio, J. Beto, K. Bolton, B. Chavers et al., Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative, American Journal of Transplantation, vol.130, issue.s7, pp.13-53, 2004.
DOI : 10.1038/sj.ejcn.1600559

N. Issa, S. B. Fatica, R. Nurko, S. Krishnamurthi, V. Goldfarb et al., Donor Factors Influencing Graft Outcomes in Live Donor Kidney Transplantation, Transplantation, vol.83, issue.5, pp.593-599, 2007.
DOI : 10.1097/01.tp.0000256284.78721.ba

E. Dimeny, G. Tufveson, H. Lithell, E. Larsson, A. Siegbahn et al., The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation, European Journal of Clinical Investigation, vol.3, issue.9, pp.572-579, 1993.
DOI : 10.1038/ki.1991.92

P. Hamar, V. Muller, M. Kohnle, O. Witzke, K. Albrecht et al., METABOLIC FACTORS HAVE A MAJOR IMPACT ON KIDNEY ALLOGRAFT SURVIVAL, Transplantation, vol.64, issue.8, pp.1135-1139, 1997.
DOI : 10.1097/00007890-199710270-00009

K. Wissing, D. Abramowicz, N. Broeders, and P. Vereerstraeten, HYPERCHOLESTEROLEMIA IS ASSOCIATED WITH INCREASED KIDNEY GRAFT LOSS CAUSED BY CHRONIC REJECTION IN MALE PATIENTS WITH PREVIOUS ACUTE REJECTION, Transplantation, vol.70, issue.3, pp.464-472, 2000.
DOI : 10.1097/00007890-200008150-00012

J. Bosmans, P. Holvoet, S. Dauwe, D. Ysebaert, T. Chapelle et al., Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 11/2 years, Kidney International, vol.59, issue.6, pp.2346-2356, 2001.
DOI : 10.1046/j.1523-1755.2001.00752.x

E. Grone, A. Walli, H. Grone, B. Miller, and D. Seidel, The role of lipids in nephrosclerosis and glomerulosclerosis, Atherosclerosis, vol.107, issue.1, pp.1-13, 1994.
DOI : 10.1016/0021-9150(94)90136-8

T. Takemura, K. Yoshioka, N. Aya, K. Murakami, A. Matumoto et al., Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases, Kidney International, vol.43, issue.4, pp.918-927, 1993.
DOI : 10.1038/ki.1993.129

A. Chade, O. Mushin, X. Zhu, M. Rodriguez-porcel, J. Grande et al., Pathways of Renal Fibrosis and Modulation of Matrix Turnover in Experimental Hypercholesterolemia, Hypertension, vol.46, issue.4, pp.772-779, 2005.
DOI : 10.1161/01.HYP.0000184250.37607.da

A. Chade, M. Rodriguez-porcel, J. Grande, X. Zhu, V. Sica et al., Mechanisms of Renal Structural Alterations in Combined Hypercholesterolemia and Renal Artery Stenosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.7, pp.1295-1301, 2003.
DOI : 10.1161/01.ATV.0000077477.40824.52

J. Mehta, N. Sanada, C. Hu, J. Chen, A. Dandapat et al., Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet, Circulation Research, vol.100, issue.11, pp.1634-1642, 2007.
DOI : 10.1161/CIRCRESAHA.107.149724

T. Sawamura, N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa et al., An endothelial receptor for oxidized low-density lipoprotein, Nature, vol.386, issue.6620, pp.73-77, 1997.
DOI : 10.1038/386073a0

J. Mehta, J. Chen, P. Hermonat, F. Romeo, and G. Novelli, Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders, Cardiovascular Research, vol.69, issue.1, pp.36-45, 2006.
DOI : 10.1016/j.cardiores.2005.09.006

L. Cominacini, A. Pasini, U. Garbin, A. Davoli, M. Tosetti et al., Oxidized Low Density Lipoprotein (ox-LDL) Binding to ox-LDL Receptor-1 in Endothelial Cells Induces the Activation of NF-kappa B through an Increased Production of Intracellular Reactive Oxygen Species, Journal of Biological Chemistry, vol.275, issue.17, pp.12633-12638, 2000.
DOI : 10.1074/jbc.275.17.12633

R. Vogel, Cholesterol lowering and endothelial function, The American Journal of Medicine, vol.107, issue.5, pp.479-487, 1999.
DOI : 10.1016/S0002-9343(99)00261-2

C. Hu, A. Dandapat, L. Sun, J. Khan, Y. Liu et al., Regulation of TGF??1-mediated Collagen Formation by LOX-1: Studies Based on Forced Overexpression of TGF??1 in Wild-Type and Lox-1, Journal of Biological Chemistry, vol.283, issue.16, pp.10226-10231, 2008.
DOI : 10.1074/jbc.M708820200

J. Cau, F. Favreau, J. Tillement, L. Lerman, T. Hauet et al., Trimetazidine reduces early and long-term effects of experimental renal warm ischemia: A dose effect study, Journal of Vascular Surgery, vol.47, issue.4, pp.852-860, 2008.
DOI : 10.1016/j.jvs.2007.10.036

C. Jayle, J. Faure, R. Thuillier, J. Goujon, J. Richer et al., Influence of nephron mass and a phosphorylated 38 mitogen-activated protein kinase inhibitor on the development of early and long-term injury after renal warm ischaemia, British Journal of Surgery, vol.67, issue.7, pp.799-808, 2009.
DOI : 10.1002/bjs.6589

P. Grimm, P. Nickerson, J. Gough, R. Mckenna, E. Stern et al., Computerized Image Analysis of Sirius Red-Stained Renal Allograft Biopsies as a Surrogate Marker to Predict Long-Term Allograft Function, Journal of the American Society of Nephrology, vol.14, issue.6, pp.1662-1668, 2003.
DOI : 10.1097/01.ASN.0000066143.02832.5E

F. Favreau, X. Zhu, J. Krier, J. Lin, L. Warner et al., Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure, Kidney International, vol.78, issue.11, pp.1110-1118, 2010.
DOI : 10.1038/ki.2010.142

A. Bedel, A. Negre-salvayre, S. Heeneman, M. Grazide, J. Thiers et al., E-Cadherin/??-Catenin/T-Cell Factor Pathway Is Involved in Smooth Muscle Cell Proliferation Elicited by Oxidized Low-Density Lipoprotein, Circulation Research, vol.103, issue.7, pp.694-701, 2008.
DOI : 10.1161/CIRCRESAHA.107.166405
URL : https://hal.archives-ouvertes.fr/hal-00355133

P. Brazy, J. Pirsch, and F. Belzer, Factors Affecting Renal Allograft Function in Long-Term Recipients, American Journal of Kidney Diseases, vol.19, issue.6, pp.558-566, 1992.
DOI : 10.1016/S0272-6386(12)80835-3

B. Hu, D. Li, T. Sawamura, and J. Mehta, Oxidized LDL through LOX-1 modulates LDL-receptor expression in human coronary artery endothelial cells, Biochemical and Biophysical Research Communications, vol.307, issue.4, pp.1008-1012, 2003.
DOI : 10.1016/S0006-291X(03)01295-6

D. Li, Y. B. Mehta, and J. , Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas, Am J Physiol Heart Circ Physiol, vol.275, pp.568-576, 1998.

S. Das, . Snehlata, N. Das, and L. Srivastava, Role of ascorbic acid on in vitro oxidation of low-density lipoprotein derived from hypercholesterolemic patients, Clinica Chimica Acta, vol.372, issue.1-2, pp.202-205, 2006.
DOI : 10.1016/j.cca.2006.03.016

A. Chade, M. Rodriguez-porcel, J. Grande, J. Krier, A. Lerman et al., Distinct Renal Injury in Early Atherosclerosis and Renovascular Disease, Circulation, vol.106, issue.9, pp.1165-1171, 2002.
DOI : 10.1161/01.CIR.0000027105.02327.48

M. Bentley, M. Rodriguez-porcel, A. Lerman, M. Sarafov, J. Romero et al., Enhanced renal cortical vascularization in experimental hypercholesterolemia, Kidney International, vol.61, issue.3, pp.1056-1063, 2002.
DOI : 10.1046/j.1523-1755.2002.00211.x

P. Holvoet, G. Theilmeier, B. Shivalkar, W. Flameng, and C. D. , LDL Hypercholesterolemia Is Associated With Accumulation of Oxidized LDL, Atherosclerotic Plaque Growth, and Compensatory Vessel Enlargement in Coronary Arteries of Miniature Pigs, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.18, issue.3, pp.415-422, 1998.
DOI : 10.1161/01.ATV.18.3.415

E. Kulah, O. Tascilar, S. Acikgoz, I. Tekin, G. Karadeniz et al., Oxidized LDL Accumulation in Experimental Renal Ischemia Reperfusion Injury Model, Renal Failure, vol.86, issue.7, pp.409-415, 2007.
DOI : 10.1161/01.ATV.0000033829.14012.18

A. Kandoussi, F. Glowacki, P. Duriez, A. Tacquet, J. Fruchart et al., Evolution Pattern of Auto-Antibodies against Oxidized Low-Density Lipoproteins in Renal Transplant Recipients, Nephron, vol.89, issue.3, pp.303-308, 2001.
DOI : 10.1159/000046090

F. Favreau, I. Petit-paris, T. Hauet, D. Dutheil, Y. Papet et al., Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ischemia???reperfusion, Free Radical Biology and Medicine, vol.36, issue.8, pp.1034-1042, 2004.
DOI : 10.1016/j.freeradbiomed.2004.01.010

N. Yun, J. Kang, and S. Lee, Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties, The Journal of Nutritional Biochemistry, vol.23, issue.10, pp.1249-1255, 2012.
DOI : 10.1016/j.jnutbio.2011.06.018

C. Manna, V. Migliardi, P. Golino, A. Scognamiglio, P. Galletti et al., Oleuropein prevents oxidative myocardial injury induced by ischemia and reperfusion, The Journal of Nutritional Biochemistry, vol.15, issue.8, pp.461-466, 2004.
DOI : 10.1016/j.jnutbio.2003.12.010

N. Perico, D. Cattaneo, M. Sayegh, and G. Remuzzi, Delayed graft function in kidney transplantation, The Lancet, vol.364, issue.9447, pp.1814-1827, 2004.
DOI : 10.1016/S0140-6736(04)17406-0

L. Henderson, B. Nankivell, and J. Chapman, Surveillance Protocol Kidney Transplant Biopsies: Their Evolving Role in Clinical Practice, American Journal of Transplantation, vol.84, issue.Suppl 1, pp.1570-1575, 2011.
DOI : 10.1111/j.1600-6143.2011.03677.x

C. Legendre, E. Thervet, H. Skhiri, M. Mamzer-bruneel, F. Cantarovich et al., HISTOLOGIC FEATURES OF CHRONIC ALLOGRAFT NEPHROPATHY REVEALED BY PROTOCOL BIOPSIES IN KIDNEY TRANSPLANT RECIPIENTS, Transplantation, vol.65, issue.11, pp.1506-1509, 1998.
DOI : 10.1097/00007890-199806150-00020

S. Harris, B. Coupes, S. Roberts, I. Roberts, C. Short et al., TGF-beta1 in chronic allograft nephropathy following renal transplantation, J Nephrol, vol.20, pp.177-185, 2007.

Y. Kanwar, TGF-?? and Renal Fibrosis, The American Journal of Pathology, vol.181, issue.4, pp.1147-1150, 2012.
DOI : 10.1016/j.ajpath.2012.08.002

M. Yanagita, Inhibitors/antagonists of TGF-?? system in kidney fibrosis, Nephrology Dialysis Transplantation, vol.27, issue.10, pp.3686-3691, 2012.
DOI : 10.1093/ndt/gfs381

C. Hu, J. Chen, A. Dandapat, Y. Fujita, N. Inoue et al., LOX-1 abrogation reduces myocardial ischemia???reperfusion injury in mice, Journal of Molecular and Cellular Cardiology, vol.44, issue.1, pp.76-83, 2008.
DOI : 10.1016/j.yjmcc.2007.10.009

C. Hu, A. Dandapat, J. Chen, Y. Fujita, N. Inoue et al., LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia???reperfusion, Cardiovascular Research, vol.76, issue.2, pp.292-302, 2007.
DOI : 10.1016/j.cardiores.2007.07.003

W. Burns and M. Thomas, The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology, Expert Reviews in Molecular Medicine, vol.159, p.17, 2010.
DOI : 10.1038/cr.2008.328

C. Noll, J. Hamelet, E. Matulewicz, J. Paul, J. Delabar et al., Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice, The Journal of Nutritional Biochemistry, vol.20, issue.8, pp.586-596, 2009.
DOI : 10.1016/j.jnutbio.2008.06.002

A. Chade, P. Best, M. Rodriguez-porcel, J. Herrmann, X. Zhu et al., Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia, Kidney International, vol.64, issue.3, pp.962-969, 2003.
DOI : 10.1046/j.1523-1755.2003.00170.x

A. Chade, M. Rodriguez-porcel, J. Herrmann, X. Zhu, J. Grande et al., Antioxidant Intervention Blunts Renal Injury in Experimental Renovascular Disease, Journal of the American Society of Nephrology, vol.15, issue.4, pp.958-966, 2004.
DOI : 10.1097/01.ASN.0000117774.83396.E9

A. Chade, M. Bentley, X. Zhu, M. Rodriguez-porcel, S. Niemeyer et al., Antioxidant Intervention Prevents Renal Neovascularization in Hypercholesterolemic Pigs, Journal of the American Society of Nephrology, vol.15, issue.7, pp.1816-1825, 2004.
DOI : 10.1097/01.ASN.0000130428.85603.6B

M. Minami, N. Kume, H. Kataoka, M. Morimoto, K. Hayashida et al., Transforming Growth Factor-??1 Increases the Expression of Lectin-like Oxidized Low-Density Lipoprotein Receptor-1, Biochemical and Biophysical Research Communications, vol.272, issue.2, pp.357-361, 2000.
DOI : 10.1006/bbrc.2000.2778

G. Draude and R. Lorenz, TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages, Am J Physiol Heart Circ Physiol, vol.278, pp.1042-1048, 2000.

D. Li and J. Mehta, Upregulation of Endothelial Receptor for Oxidized LDL (LOX-1) by Oxidized LDL and Implications in Apoptosis of Human Coronary Artery Endothelial Cells : Evidence From Use of Antisense LOX-1 mRNA and Chemical Inhibitors, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.4, pp.1116-1122, 2000.
DOI : 10.1161/01.ATV.20.4.1116

L. Rossard, F. Favreau, S. Giraud, R. Thuillier, L. Pape et al., Role of warm ischemia on innate and adaptive responses in a preclinical renal auto-transplanted porcine model, Journal of Translational Medicine, vol.11, issue.1, p.129, 2013.
DOI : 10.1097/MOT.0b013e3283446b1d
URL : https://hal.archives-ouvertes.fr/inserm-00827220

J. Lu, X. Wang, W. Wang, H. Muniyappa, C. Hu et al., LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse, Gene Therapy, vol.101, issue.5, pp.522-531, 2012.
DOI : 10.1161/CIRCRESAHA.109.196154

J. Lu, X. Wang, W. Wang, H. Muniyappa, A. Deshmukh et al., Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation, Kidney International, vol.82, issue.4, pp.436-444, 2012.
DOI : 10.1038/ki.2012.186

S. Giraud, F. Favreau, N. Chatauret, R. Thuillier, S. Maiga et al., Contribution of Large Pig for Renal Ischemia-Reperfusion and Transplantation Studies: The Preclinical Model, Journal of Biomedicine and Biotechnology, vol.8, issue.19, pp.2011-532127, 2011.
DOI : 10.1152/ajpheart.01100.2009

B. Fellstrom, H. Holdaas, A. Jardine, I. Holme, G. Nyberg et al., Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial, Kidney International, vol.66, issue.4, pp.1549-1555, 2004.
DOI : 10.1111/j.1523-1755.2004.00919.x

H. Holdaas, B. Fellstrom, A. Jardine, G. Nyberg, C. Gronhagen-riska et al., Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation, Nephrology Dialysis Transplantation, vol.20, issue.5, pp.974-980, 2005.
DOI : 10.1093/ndt/gfh735